The BRAF-mutant tumor samples also contained elevated levels of macrophages, mucosal-associated invariant T cells, cancer-associated fibroblasts, hematopoietic stem cells, common myeloid progenitors, myeloid dendritic cells, and CD4+ T cells compared to the BRAF-wild-type tumor samples. This evidence concerns the gene CD4 and neoplasm.